A detailed history of State Street Corp transactions in Inotiv, Inc. stock. As of the latest transaction made, State Street Corp holds 68,929 shares of NOTV stock, worth $303,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,929
Previous 68,929 -0.0%
Holding current value
$303,976
Previous $114,000 2.63%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.66 - $9.87 $1,494 - $8,883
900 Added 1.32%
68,929 $114,000
Q1 2024

May 15, 2024

SELL
$3.27 - $11.04 $5,232 - $17,664
-1,600 Reduced 2.3%
68,029 $744,000
Q4 2023

Feb 14, 2024

BUY
$1.69 - $3.86 $13,351 - $30,494
7,900 Added 12.8%
69,629 $255,000
Q3 2023

Nov 14, 2023

BUY
$3.01 - $7.32 $2,408 - $5,856
800 Added 1.31%
61,729 $190,000
Q2 2023

Aug 14, 2023

SELL
$4.08 - $7.22 $1.14 Million - $2.02 Million
-279,756 Reduced 82.12%
60,929 $290,000
Q1 2023

May 15, 2023

BUY
$4.18 - $8.64 $51,660 - $106,781
12,359 Added 3.76%
340,685 $1.48 Million
Q4 2022

Feb 14, 2023

BUY
$3.77 - $22.1 $46,649 - $273,465
12,374 Added 3.92%
328,326 $1.62 Million
Q3 2022

Nov 15, 2022

BUY
$9.81 - $26.17 $174,618 - $465,826
17,800 Added 5.97%
315,952 $5.32 Million
Q2 2022

Aug 15, 2022

SELL
$9.56 - $25.91 $214,669 - $581,809
-22,455 Reduced 7.0%
298,152 $2.86 Million
Q1 2022

May 16, 2022

BUY
$18.52 - $40.41 $632,532 - $1.38 Million
34,154 Added 11.92%
320,607 $8.39 Million
Q4 2021

Feb 14, 2022

SELL
$30.55 - $57.88 $1.6 Million - $3.02 Million
-52,233 Reduced 15.42%
286,453 $12.1 Million
Q3 2021

Nov 15, 2021

BUY
$23.69 - $49.93 $733,797 - $1.55 Million
30,975 Added 10.07%
338,686 $9.9 Million
Q2 2021

Aug 16, 2021

BUY
$18.9 - $31.42 $5.82 Million - $9.67 Million
307,711 New
307,711 $8.21 Million

Others Institutions Holding NOTV

About Inotiv, Inc.


  • Ticker NOTV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 25,594,500
  • Market Cap $113M
  • Description
  • Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...
More about NOTV
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.